American multinational pharmaceutical company Pfizer has completed its phase 3 trial of its COVID-19 vaccine candidate and has found its vaccine to be 95% effective against the respiratory illness. The company is currently seeking emergency use approval from the US Food and Drug Administration (FDA).
from Sputnik News - World News, Breaking News & Top Stories https://ift.tt/36pM77I
via IFTTT
No comments:
Post a Comment